Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating beri-beri

A drug and athlete's foot technology, applied in the field of medicine, can solve the problems of low cure rate and slow drug effect, and achieve the effect of low price, short course of treatment and inhibition of fungal infection

Inactive Publication Date: 2005-01-12
李文章
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Athlete's foot, also known as Hong Kong's foot, is a contagious skin disease caused by fungi, mainly characterized by itchy toes. It is mainly treated with external medicines such as agent, ointment or powder, such as dacryline and foot light powder. Although these drugs have a certain curative effect, it is clinically shown that these drugs take effect slowly and the cure rate is not high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0012] Example 1: Taking the preparation of 100 kilograms of medicinal powder as an example, 15 kilograms of calamine, 5 kilograms of borneol, 5 kilograms of realgar, 5 kilograms of sulfur, 5 kilograms of light powder, 2.5 kilograms of Xinshi, 20 kilograms of chlorpheniramine, diphenhydramine 12.5 kg, griseofulvin 5 kg and vitamin B1 25 kg. The above-mentioned components of the drug are respectively pulverized into 100-mesh fine powder, mixed uniformly, and sterilized to obtain the powder of the drug.

Embodiment 2

[0013] Example 2: Taking the preparation of 200 kg of ointment as an example, 17.5 kg of calamine, 5 kg of borneol, 5 kg of realgar, 5 kg of sulfur, 5 kg of light powder, 3 kg of letter stone, 21 kg of chlorpheniramine, diphenhydramine 10 kg, griseofulvin 6 kg and vitamin B1 22.5 kg. The drug ointment can be obtained by pulverizing the above-mentioned components into 100-mesh fine powder, mixing with 100 kg of petrolatum, and sterilizing.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A medicine for treating beriberi is prepared from 10 raw materials including borneol, realgar, sulfur, chlorpheniramine, benadryl, griseofulvin, VB1, etc.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating beriberi. Background technique [0002] Athlete's foot, also known as Hong Kong's foot, is a contagious skin disease caused by fungi, mainly characterized by itchy toes. It is mainly treated with external medicines such as agent, ointment or powder, such as dacryline and foot light powder. Though these medicines have certain curative effect, clinical show these medicines take effect slowly, and cure rate is not high. Contents of the invention [0003] The object of the invention is to provide a medicine for treating beriberi with quick effect and high cure rate. [0004] The objective solution of the present invention is based on the understanding of the etiology and pathology of beriberi, and according to the inventor's many years of clinical practice, it is processed through screening and compatibility. [0005] The medicine of the present invention is composed of calam...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K33/36A61P17/00A61P31/10
Inventor 李文章
Owner 李文章
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products